about
The Cyclic Cystine Ladder in -Defensins Is Important for Structure and Stability, but Not Antibacterial ActivityIn Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered CyclotideAntimicrobial Peptides from PlantsComputational Design of Hypothetical New Peptides Based on a Cyclotide Scaffold as HIV gp120 InhibitorBiological synthesis of circular polypeptidesPhosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions.Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometryMolecular evolution of the primate α-/θ-defensin multigene family.Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptorsIntein applications: from protein purification and labeling to metabolic control methods.Optimizing structural modeling for a specific protein scaffold: knottins or inhibitor cystine knots.Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential.Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.Characterizing circular peptides in mixtures: sequence fragment assembly of cyclotides from a violet plant by MALDI-TOF/TOF mass spectrometry.Dynamic scenario of membrane binding process of kalata b1Recombinant expression of backbone-cyclized polypeptides.Optimization of the cyclotide framework to improve cell penetration properties.Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activitiesSpider-venom peptides as therapeutics.Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach.PredSTP: a highly accurate SVM based model to predict sequential cystine stabilized peptides.Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics.Cyclotides, a novel ultrastable polypeptide scaffold for drug discoveryDesign of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity.Cyclotide discovery in Gentianales revisited--identification and characterization of cyclic cystine-knot peptides and their phylogenetic distribution in Rubiaceae plants.Defining the membrane disruption mechanism of kalata B1 via coarse-grained molecular dynamics simulations.Peptide promiscuity: an evolutionary concept for plant defense.Cyclotides: a patent review.Cyclotides as a basis for drug design.Chemical synthesis of circular proteins.Joseph Rudinger memorial lecture: discovery and applications of cyclotides.Patchwork protein chemistry: a practitioner's treatise on the advances in synthetic peptide stitchery.Cyclotides as grafting frameworks for protein engineering and drug design applications.Serine/threonine ligation for natural cyclic peptide syntheses.Discovery, isolation, and structural characterization of cyclotides from Viola sumatrana Miq.Plant cystine-knot peptides: pharmacological perspectives.Approaches to the stabilization of bioactive epitopes by grafting and peptide cyclization.Discovery, structure, function, and applications of cyclotides: circular proteins from plants.Design of cyclized selective melanotropins.
P2860
Q27676502-6F481B43-0B3E-4123-86CB-A5CD62CD8DDEQ27679062-C70E72A0-9C1E-4C87-8172-9B0190E4C6CAQ28082004-65540A00-149C-444D-B676-249984190F84Q28550563-A434A514-8C90-45FD-80F2-96ECF17D8EF4Q30418154-25BEE205-FEC8-47AA-ACE8-B601F08ACD44Q30525336-056E35C3-65CC-422C-A6A8-916786AFF57CQ31031875-3BF362C6-4869-4974-9BB8-26A09140D0A0Q31161057-6CAC7A0A-1625-41CA-A4F6-8E848F7F97C9Q33650270-1D543363-5CEA-483D-816D-9151ABD8CDF6Q33652036-6054B487-0D49-4CB4-8900-2B3B7C756C09Q33732145-95E0AF77-A0E1-491D-AA20-9CAE6423DA64Q33948546-5FE8C8B0-9B61-422D-8414-02A0D975DF8AQ34004482-1A3F13BB-487B-4F51-8470-5EC97EB03580Q34378974-B3C57B89-D02E-4697-9D08-FE0FFD9943ECQ34634734-2C00EB92-33EA-47DC-AEE6-3B4C5B910FF8Q34871830-471AF072-62CE-40CD-9BDB-D91D291492DAQ35063455-3F299468-04DB-4DD8-91AB-88BDA0C6D6ECQ35085127-CFC5AE20-4FFA-44E8-839F-AC8A33AD8066Q35155666-E3E89983-120C-4CB6-99C2-075BDD8F276DQ35557929-8605F19A-CA53-4BDD-888D-8DD989C1491EQ35682704-BDADCC0B-2E08-4976-A4C5-86127CA42044Q35893500-FFF424D5-AE1C-4A9B-94F1-B09BD32C57BAQ35900582-A6B3563F-FA9A-4251-81D3-372C8F8FAE73Q36465556-B958CCAB-9B09-4B29-9992-482640A818B5Q36695598-254DA0DC-C75E-441F-A28B-6B7D07C9C73AQ37276283-78B6D3C8-B0BE-42F1-A822-6E8CBB4999E4Q37542954-986D2D59-9F6D-4B42-83FC-C226B2E74FA7Q37852827-720A53AC-6111-4E55-849B-BCC335D3365BQ37948106-CE96F722-9CDB-4113-AC8D-A73FCA02E62AQ37999102-7D9C90F3-AE89-48BC-9D9F-ADADA5F95E6CQ38018920-12D16F1F-E0FC-4F94-ACC5-9278DD66BC56Q38112084-A8B3131D-A037-4A30-90DC-6E48D8847D1DQ38115259-4BD6455E-84AC-4CB2-B6FC-31C6822C01B6Q38124801-202BE375-DFBC-4CCA-BE6E-FED7608B38A3Q38507318-B6E072BB-E563-439E-B6DC-D3E8030CBFE5Q38758642-2755A560-3B10-4D4F-BE8E-AB4CF5BD01FBQ38778694-16F7EC10-8AE8-4719-8E8C-B36A3BB668DAQ38819655-2F6135F0-D5D1-41B4-8D11-59097577F331Q38843873-8E0085EA-5F92-462A-9005-D05713EA1780Q38937114-07859F2B-6F92-400A-82EC-ACBE4EC0510B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclotides as templates in drug design.
@en
Cyclotides as templates in drug design.
@nl
type
label
Cyclotides as templates in drug design.
@en
Cyclotides as templates in drug design.
@nl
prefLabel
Cyclotides as templates in drug design.
@en
Cyclotides as templates in drug design.
@nl
P1433
P1476
Cyclotides as templates in drug design.
@en
P356
10.1016/J.DRUDIS.2009.10.007
P577
2009-10-28T00:00:00Z